Craig W. Menges

1.8k total citations
28 papers, 1.3k citations indexed

About

Craig W. Menges is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Craig W. Menges has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Craig W. Menges's work include Occupational and environmental lung diseases (14 papers), Medical Imaging and Pathology Studies (5 papers) and Cancer-related Molecular Pathways (4 papers). Craig W. Menges is often cited by papers focused on Occupational and environmental lung diseases (14 papers), Medical Imaging and Pathology Studies (5 papers) and Cancer-related Molecular Pathways (4 papers). Craig W. Menges collaborates with scholars based in United States, United Kingdom and Russia. Craig W. Menges's co-authors include Joseph R. Testa, Dennis J. McCance, Yuwaraj Kadariya, Deborah A. Altomare, Jianming Pei, Mitchell Cheung, Laurel A. Baglia, Eleonora Sementino, Jinfei Xu and Andres J. Klein–Szanto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Craig W. Menges

28 papers receiving 1.3k citations

Peers

Craig W. Menges
Yinfei Tan United States
Diarmuid Moran United States
Douglas B. Stairs United States
Jianzhong Huang United States
Young A. Yoo South Korea
Yinfei Tan United States
Craig W. Menges
Citations per year, relative to Craig W. Menges Craig W. Menges (= 1×) peers Yinfei Tan

Countries citing papers authored by Craig W. Menges

Since Specialization
Citations

This map shows the geographic impact of Craig W. Menges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig W. Menges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig W. Menges more than expected).

Fields of papers citing papers by Craig W. Menges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig W. Menges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig W. Menges. The network helps show where Craig W. Menges may publish in the future.

Co-authorship network of co-authors of Craig W. Menges

This figure shows the co-authorship network connecting the top 25 collaborators of Craig W. Menges. A scholar is included among the top collaborators of Craig W. Menges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig W. Menges. Craig W. Menges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menges, Craig W., et al.. (2024). Alterations of the AKT Pathway in Sporadic Human Tumors, Inherited Susceptibility to Cancer, and Overgrowth Syndromes. Current topics in microbiology and immunology. 1 indexed citations
2.
Menges, Craig W., et al.. (2024). AKT kinases as therapeutic targets. Journal of Experimental & Clinical Cancer Research. 43(1). 313–313. 20 indexed citations
3.
Tan, Yinfei, Eleonora Sementino, Mitchell Cheung, et al.. (2020). Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma. Clinical Cancer Research. 27(4). 1200–1213. 38 indexed citations
4.
Emmett, Edward A., Brenda B. Casper, Dan Blanchon, et al.. (2020). Challenging Global Waste Management – Bioremediation to Detoxify Asbestos. Frontiers in Environmental Science. 8. 24 indexed citations
5.
Sementino, Eleonora, Yuwaraj Kadariya, Craig W. Menges, et al.. (2019). Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models. Cancer Research. 79(16). 4113–4123. 41 indexed citations
6.
Sementino, Eleonora, Craig W. Menges, Yuwaraj Kadariya, et al.. (2018). Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas. Journal of Cellular Physiology. 233(11). 8952–8961. 23 indexed citations
7.
Kadariya, Yuwaraj, Craig W. Menges, Jacqueline Talarchek, et al.. (2016). Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prevention Research. 9(5). 406–414. 59 indexed citations
8.
Kadariya, Yuwaraj, Mitchell Cheung, Jinfei Xu, et al.. (2016). Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Cancer Research. 76(9). 2836–2844. 79 indexed citations
9.
Pietrofesa, Ralph A., Anastasia Velalopoulou, Evguenia Arguiri, et al.. (2015). Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice. Carcinogenesis. 37(2). 177–187. 45 indexed citations
10.
Xu, Jinfei, Yuwaraj Kadariya, Mitchell Cheung, et al.. (2014). Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma. Cancer Research. 74(16). 4388–4397. 107 indexed citations
11.
Menges, Craig W., Yuwaraj Kadariya, Deborah A. Altomare, et al.. (2013). Tumor Suppressor Alterations Cooperate to Drive Aggressive Mesotheliomas with Enriched Cancer Stem Cells via a p53–miR-34a–c-Met Axis. Cancer Research. 74(4). 1261–1271. 47 indexed citations
12.
Menges, Craig W., Eleonora Sementino, Jacqueline Talarchek, et al.. (2012). Group I p21-Activated Kinases (PAKs) Promote Tumor Cell Proliferation and Survival through the AKT1 and Raf–MAPK Pathways. Molecular Cancer Research. 10(9). 1178–1188. 40 indexed citations
13.
Pickard, Adam, et al.. (2012). Regulation of Epithelial Differentiation and Proliferation by the Stroma: A Role for the Retinoblastoma Protein. Journal of Investigative Dermatology. 132(12). 2691–2699. 14 indexed citations
14.
Altomare, Deborah A., Craig W. Menges, Jinfei Xu, et al.. (2011). Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate Tumorigenesis. PLoS ONE. 6(4). e18828–e18828. 50 indexed citations
15.
Tan, Yinfei, Mitchell Cheung, Jianming Pei, et al.. (2010). Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling. Cancer Research. 70(22). 9197–9206. 51 indexed citations
16.
17.
Menges, Craig W., Deborah A. Altomare, & Joseph R. Testa. (2009). FAS-Associated Factor 1 (FAF1): Diverse functions and implications for oncogenesis. Cell Cycle. 8(16). 2528–2534. 69 indexed citations
18.
19.
Ferbert, A., et al.. (1994). Schwere Spätdystonie nach Neuroleptikaanxiolyse mit Fluspirilen. Der Nervenarzt. 65(1). 66–68. 1 indexed citations
20.
Kappler, Joachim, Craig W. Menges, A. Ferbert, & H. Ebel. (1994). [Severe "late" dystonia after neuroleptic anxiolysis with fluspirilene].. PubMed. 65(1). 66–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026